Home | Welcome to Contract Pharma   
Last Updated Friday, May 22 2015

Print RSS Feed

Topics - Biologics, Proteins, Vaccines

Refine by Date:
From: To:
Published May 22, 2015
Expands protein detection franchise Read More »
Published May 22, 2015
To provide aseptic and low bioburden clean room dispensing of bulk materials Read More »
Published May 21, 2015
Selected for a highly specialized vaccine fill/finish project Read More »
Published May 19, 2015
Company continues to support its growing biologics portfolio Read More »
Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
Published May 12, 2015
Will support commercial-scale ADC manufacturing Read More »
Published May 12, 2015
To bolster clinical and commercial bulk drug production and fill/finish for gene therapies Read More »
Published May 12, 2015
Will collaborate to identify and validate tumor targets and corresponding TCRs in cancer Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 11, 2015
The new facility has already been deployed to manufacture a Humira biosimilar candidate in an upcoming Phase III trial Read More »
Published May 8, 2015
Additional 27,000 sq.-ft. will supply materials for clinical trials Read More »
Published May 7, 2015
Finalizes ISO 9001 and ISO 5001 Certification Read More »
Published April 30, 2015
Will be among the largest mammalian cell culture mfg. facilities using disposable bioreactors Read More »
Published April 24, 2015
Multi-purpose facility is among the largest bulk API manufacturing facilities for recombinant microbial biologics Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On